News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
DesRosier Thomas
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/07/2023 |
4
| DesRosier Thomas (Chief Legal Officer and EVP) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Granted 42,500 restricted stock units
@ $0
Granted 85,000 options to buy
@ $5.5, valued at
$467.5k
|
|
| 07/06/2022 |
4
| DesRosier Thomas (Chief Legal Officer and EVP) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Granted 63,492 shares
@ $3.15, valued at
$200k
|
|
| 02/08/2022 |
4
| DesRosier Thomas (Chief Legal Officer and EVP) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Granted 130,000 options to buy
@ $7.38, valued at
$959.4k
|
|
| 02/08/2021 |
4
| DesRosier Thomas (Chief Legal Officer and EVP) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $26.34, valued at
$2.6M
|
|
| 01/31/2020 |
4
| DesRosier Thomas (Chief Legal Officer and EVP) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Granted 350,000 options to buy
@ $3.3, valued at
$1.2M
|
|
| 01/28/2020 |
4
| DesRosier Thomas (Chief Legal Officer and EVP) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Exercised 25,000 restricted stock units
@ $0 |
|
| 01/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/30/2018 |
4
| DesRosier Thomas (See Remarks) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Sold 3,475 shares
@ $11.02, valued at
$38.3k
Exercised 10,000 restricted stock units
@ $0
Granted 80,000 options to buy
@ $10.42, valued at
$833.6k
Granted 100,000 options to buy
@ $10.42, valued at
$1M
|
|
| 01/27/2017 |
4
| DesRosier Thomas (Chief Legal Officer and EVP) has filed a Form 4 on Seres Therapeutics, Inc. |
| 06/02/2016 |
4
| DesRosier Thomas (See Remarks) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $30.9, valued at
$3.1M
|
|
| 03/30/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/09/2016 |
4
| DesRosier Thomas (EVP, General Counsel) has filed a Form 4 on ARIAD PHARMACEUTICALS INC|
Txns:
| Granted 102,500 options to buy
@ $6.51, valued at
$667.3k
Granted 30,800 restricted stock units
@ $0 |
|
| 10/02/2013 |
4
| DesRosier Thomas (SVP, Chief Legal Officer & GC) has filed a Form 4 on CUBIST PHARMACEUTICALS INC|
Txns:
| Acquired 93 shares
@ $63.55, valued at
$5.9k
|
|
| 04/16/2013 |
4
| DesRosier Thomas (SVP, Chief Legal Counsel & GC) has filed a Form 4 on CUBIST PHARMACEUTICALS INC|
Txns:
| Granted 70,207 options to buy
@ $45.9, valued at
$3.2M
Granted 9,509 restricted stock units
@ $0 |
|
| 03/27/2013 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 04/06/2011 |
4
| DesRosier Thomas (Sr VP, General Counsel) has filed a Form 4 on GENZYME CORP|
Txns:
| Unknown transaction of 5,738 shares
@ $74, valued at
$424.6k
Disposed/sold 11,375 shares
@ $74, valued at
$841.8k
Unknown transaction of 4,947 shares
@ $74, valued at
$366.1k
Unknown transaction of 779 shares
@ $74, valued at
$57.6k
Exercised 5,542 restricted stock units
@ $0
Exercised 5,833 restricted stock units
@ $0
Disposed/sold 23,038 options to buy
@ $51.52, valued at
$1.2M
Disposed/sold 16,625 options to buy
@ $58.66, valued at
$975.2k
Disposed/sold 17,500 options to buy
@ $68.48, valued at
$1.2M
Disposed/sold 17,500 options to buy
@ $62.16, valued at
$1.1M
Disposed/sold 35,000 options to buy
@ $58.5, valued at
$2M
|
|
| 06/18/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/26/2010 |
4
| DesRosier Thomas (Sr VP, General Counsel) has filed a Form 4 on GENZYME CORP|
Txns:
| Sold 1,972 shares
@ $45.6, valued at
$89.9k
Exercised 5,833 restricted stock units
@ $0 |
|
| 05/26/2009 |
4
| DesRosier Thomas (Sr VP, General Counsel) has filed a Form 4 on GENZYME CORP |
| 04/29/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
|
|